title: [Brain natriuretic peptide. Diagnostic value in heart failure].
abstract: BACKGROUND
  Nowadays a number of diverse biochemical markers have been identified in patients with heart failure (HF) that could indicate the severity of the patients' illness. Among them, probably the most useful is brain natriuretic peptide (BNP) because it is easily obtained and because of its diagnostic and prognostic information. Our objective was to assess the association between BNP and other different associated variables previously known to be related to the evolution of HF, as well as its utility to distinguish systolic from diastolic HF.
  
  
  METHODS
  We studied 114 patients admitted consecutively for symptomatic HF for all causes (age: 66 years, male: 60%). In all patients plasma BNP was measured, from the third day of admission, with a specific radioinmunoassay. Echocardiography was performed in 101 patients.
  
  
  RESULTS
  BNP plasma levels increased in proportion to functional class (p = 0.01) and the degree of left ventricular dysfunction (p = 0.0001, r = 0.44). There was also an association between BNP and male sex (p = 0.008), higher plasmatic creatinine (p = 0.01, r = 0.25), Iarger ventricular diameters (p = 0.0001) and higher pulmonary systolic pressure (p = 0.001, r = 0.44). In the multivariate analysis, BNP was independently related to the rest of variables with left systolic ventricular function (p = 0.0001). Despite this association, we did not find a satisfactory cut-off value in BNP, with a good sensitivity and specificity value from the total number of patients, of which specifically systolic dysfunction as a cause of HF was detected.
  
  
  CONCLUSIONS
  a) BNP increases proportionately to the left ventricular dysfunction and HF severity, and b) BNP is not a useful tool to distinguish systolic from diastolic HF.
authors.affiliation: Servicios de Cardiología, Hospital Universitario La Fe, Valencia, Spain. j_osca@inicia.es
authors.forename: Joaquín
authors.initials: J
authors.lastname: Osca
authors.forename: Anastasio
authors.initials: A
authors.lastname: Quesada
authors.forename: Miguel A
authors.initials: MA
authors.lastname: Arnau
authors.forename: Ana
authors.initials: A
authors.lastname: Osa
authors.forename: Isabel
authors.initials: I
authors.lastname: Hervás
authors.forename: Luis
authors.initials: L
authors.lastname: Almenar
authors.forename: Miguel
authors.initials: M
authors.lastname: Palencia
authors.forename: Antonio
authors.initials: A
authors.lastname: Mateo
authors.forename: Francisco
authors.initials: F
authors.lastname: Algarra
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D005260:Female; D006333:Heart Failure / Q000097:blood* / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D013599:Systole
chemical_list: D015415:Biomarkers; D020097:Natriuretic Peptide, Brain
vernacular_title: Péptido cerebral natriurético. Valor diagnóstico en la insuficiencia cardíaca.